ATSUSHI HOSUI | Oncology Pharmaceuticals | Pharmaceutical Excellence Award
Dr. ATSUSHI HOSUI, Osaka Rosai Hospital, Japan
Dr. Atsushi Hosui, a distinguished hepatologist, earned his M.D. from Osaka University in 1994 š. With Japanese Medical License #363021, he holds multiple board certifications in internal medicine, gastroenterology, and hepatology š„. Currently serving as Director of Hepatology at Osaka Rosai Hospital, he has led and contributed to numerous clinical trials on NASH, MASH, PBC, and liver cancer š§¬. A member of Japanās leading medical societies, he is also GCP-trained (2015) š. Renowned for his impactful research and over 30 scientific publications, Dr. Hosui is a trailblazer in liver disease therapeutics and pharmaceutical excellence.
Publication ProfileĀ
Education
Dr. Atsushi Hosui embarked on his medical journey at the prestigious Osaka University, Japan š¾, where he earned his Doctor of Medicine (M.D.) degree in March 1994 š. Renowned for its excellence in medical education and research, Osaka University provided him with a solid foundation in clinical medicine and scientific inquiry š§Ŗ. His education laid the groundwork for a remarkable career in gastroenterology and hepatology š„. Driven by a passion for improving liver health, Dr. Hosui has since become a respected physician, researcher, and clinical investigator, dedicated to advancing pharmaceutical science and patient care globally.
Awards
Dr. Atsushi Hosui holds a prestigious Japanese Medical License (#363021) šÆšµ, validating his long-standing commitment to clinical excellence. He is a board-certified member and specialist of the Japanese Society of Internal Medicine š§¬, where he also serves as an advising doctor šØāāļø. His specialization extends to gastroenterology and hepatology, holding certified status from the Japanese Society of Gastroenterology š„, the Japan Society of Hepatology š, and the Japan Gastroenterological Endoscopy Society š¬. These recognitions underscore his expertise in digestive health and liver diseases, reflecting a distinguished career devoted to patient care and research innovation.
Experience
Dr. Atsushi Hosui has led and contributed to numerous groundbreaking clinical research projects in hepatology and internal medicine š§¬. As an investigator or sub-investigator, he played key roles in studies on NASH (2021ā2022) and MASH (2024ā2025) š©ŗ. His focus on hypozincemia (2015), hepatocellular carcinoma (2012ā2016), portal vein thrombosis (2015ā2016), and PBC (2025ā) highlights his expertise in liver-related conditions š§ . He also contributed significantly to studies on thrombocytopenia and chronic hepatitis C (2013) š§«. Dr. Hosuiās research dedication reflects his mission to improve liver health and advance pharmaceutical excellence globally.
Research Focus
Dr. Atsushi Hosuiās research is centered around hepatology and gastroenterology, with a strong emphasis on hepatocellular carcinoma (HCC) š§«, chronic liver diseases š„, and vascular complications like gastric varices and Budd-Chiari syndrome š«. His clinical investigations span topics such as portal hypertension, black esophagus, hyperglycemic complications, and the long-term risks of hepatitis B treatments š¦ . His innovative approaches combine locoregional therapies, embolization techniques, and pharmacologic interventions to enhance liver cancer outcomes šÆ. Dr. Hosuiās work bridges diagnostic precision with therapeutic advancements in liver-related pathologies, reinforcing his role as a leader in hepatic disease management.
Publication Top Notes
- Management of Gastric Varices with Portopulmonary Venous Anastomosis: A Combined Approach Using Percutaneous Transhepatic Coil Embolization and Balloon-Occluded Retrograde Transvenous Obliteration
- Efficacy of Adding Locoregional Therapy in ATZ/BEV-Treated Patients with Stable HCC
- Black Esophagus in Hyperosmolar Hyperglycemic Syndrome
- The Risk of Developing Hepatocellular Carcinoma Persists in Chronic Hepatitis B Patients Even After the Long-Term Administration of Nucleos(t)ide Analogs
- Solitary Cardiac Metastasis of Hepatocellular Carcinoma
- Hepatocellular Carcinoma Associated with Secondary Budd-Chiari Syndrome